A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer

Oncology

Volumn 79, Issue 5-6, 2011, Pages 382-388

  Citrin, Deborah ^a   Camphausen, Kevin ^a   Wood, Bradford J ^b   Quezado, Martha ^c   Denobile, John ^d   Pingpank, James F ^a   Royal, Richard E ^a   Alexander, H Richard ^e,f   Seidel, Geoffrey ^g   Steinberg, Seth M ^a   Shuttack, Yvonne ^g   Libutti, Steven K ^a,h  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e Division of Surgical Oncology   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g SAIC FREDERICK INC   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Neoadjuvant; Radiation; Rectal carcinoma; TNFerade

Indexed keywords

CAPECITABINE; GOLNERMINOGENE PRADENOVEC;

ABDOMINAL PAIN; ADULT; ADVANCED CANCER; ANEMIA; ANOREXIA; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTERITIS; EPISTAXIS; FATIGUE; FEASIBILITY STUDY; FEMALE; FEVER; HUMAN; HYPONATREMIA; HYPOPHOSPHATEMIA; LEUKOPENIA; LIVER FUNCTION; LYMPHOCYTOPENIA; MALE; NAUSEA; NEUTROPENIA; PILOT STUDY; PRIORITY JOURNAL; RADIATION DOSE; RASH; RECTUM CANCER; RIGOR; SIDE EFFECT; SMALL INTESTINE OBSTRUCTION; THROMBOSIS; VOMITING;

ADULT; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; GENE THERAPY; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PILOT PROJECTS; RECTAL NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79953062841     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323488     Document Type: Article

References (28)

1. Jemal A, et al: Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Fisher B, et al: Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988; 80: 21-29. (Pubitemid 18076565)
3. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group. N Engl J Med 1985; 312: 1465-1472.
4. Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party. Lancet 1996; 348: 1605-1610.
5. Thomas PR, Lindblad AS: Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol 1988; 13: 245-252. (Pubitemid 19009239)
6. Wolmark N, et al: Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000; 92: 388-396. (Pubitemid 30154820)
7. Sauer R, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
8. Old LJ: Tumor necrosis factor (TNF). Science 1985; 230: 630-632.
9. Gridley DS, Hammond SN, Liwnicz BH: Tumor necrosis factor-alpha augments radiation effects against human colon tumor xenografts. Anticancer Res 1994; 14: 1107-1112.
10. Weichselbaum RR, et al: Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 1994; 54: 4266-4269. (Pubitemid 24273130)
11. Hallahan DE, et al: Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1995; 1: 786-791.
12. Hallahan DE, et al: Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy. Cancer J Sci Am 1995; 1: 204-209.
13. Murugesan SR, et al: Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer. Cancer Gene Ther 2009; 16: 841-847.
14. Weichselbaum RR, Kufe D: Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers. Cancer Gene Ther 2009; 16: 609-619.
15. Mundt AJ, et al: A phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities. Clin Cancer Res 2004; 10: 5747-5753. (Pubitemid 39180951)
16. Sharma A, et al: Clinical protocol. An openlabel, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. Hum Gene Ther 2001; 12: 1109-1131. (Pubitemid 32692426)
17. Chang KJ, et al: Endoscopic ultrasound delivery of an antitumor agent to treat a case of pancreatic cancer. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 107-111. (Pubitemid 351234280)
18. Sudheendra D, et al: Comparison of three different needles for percutaneous injections. Cardiovasc Intervent Radiol 2007; 30: 151-152. (Pubitemid 44900513)
19. Wheeler JM, et al: Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis Colon Rectum 2002; 45: 1051-1056.
20. Wolff HA, et al: High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer. Strahlenther Onkol 2010; 186: 30-35.
21. Bosset JF, et al: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
22. Chan AK, et al: Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61: 665-677. (Pubitemid 40247960)
23. Habr-Gama A, et al: Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005; 9: 90-99, discussion 99-101.
24. Kuo LJ, et al: Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 2007; 14: 2766-2772.
25. Rodel C, et al: Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23: 8688-8696. (Pubitemid 46211512)
26. Wheeler JM, et al: Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum 2004; 47: 2025-2031. (Pubitemid 40179060)
27. Ballonoff A, et al: Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. Am J Clin Oncol 2008; 31: 264-270.
28. Desai SP, et al: A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer. Am J Clin Oncol 2007; 30: 340-345. (Pubitemid 47356676)